Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Delcon is an Italian medtech company focused on the blood industry, designing and manufacturing medical devices and digital solutions for blood collection, processing, separation, and storage. Founded in 1981, the company serves blood centers and hospitals and also supplies diagnostic equipment in hematology and microbiology. Its commercial product portfolio includes blood collection mixers, tube sealers, blood-processing workflow tools, and software platforms such as DelcoNet and OpenChair. Delcon positions itself as a design- and innovation-driven company, combining hardware, software, and AI-enabled donor engagement tools to improve efficiency, quality, and donor experience across transfusion workflows. The company reports a presence in more than 50-70 countries through direct activity and distributor networks, with North America highlighted as an important innovation market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Delcon.